Animal models of pain for drug discovery

Expert Opinion on Drug Discovery

Volumn 1, Issue 4, 2006, Pages 323-334

  Joshi, Shailen K ^a   Honore, Prisca ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

analgesic; cancer pain; inflammatory pain; neuropathic pain; nociception; osteoarthritic pain; visceral pain

Indexed keywords

EID: 80051709491     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.4.323     Document Type: Review

References (84)

1. HARDEN N, COHEN M: Unmet needs in the management of neuropathic pain. J. Pain Symptom Manage. (2003) 25(5 Suppl):S12-S17. (Pubitemid 36411837)
2. ELLIOTT AM, SMITH BH, PENNY KI, SMITH WC, CHAMBERS WA: The epidemiology of chronic pain in the community. Lancet (1999) 354(9186):1248-1252. (Pubitemid 29469353)
3. ERIKSEN J, JENSEN MK, SJOGREN P, EKHOLM O, RASMUSSEN NK: Epidemiology of chronic non-malignant pain in Denmark. Pain (2003) 106(3):221-228. (Pubitemid 37505870)
4. SCHOLZ J,WOOLF CJ: Can we conquer pain? Nat. Neurosci. (2002) 5(Suppl):1062-1067.
5. MILLAN MJ: The induction of pain: an integrative review. Prog. Neurobiol. (1999) 57(1):1-164. (Pubitemid 28551764)
6. CERVERO F, LAIRD JM: Mechanisms of touch-evoked pain (allodynia): a new model. Pain (1996) 68(1):13-23. (Pubitemid 126407751)
7. WOOLF C, COSTIGAN M: Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc. Natl. Acad. Sci. USA (1999) 96(14):7723-7730. (Pubitemid 29328348)
8. DWORKIN RH, BACKONJA M, ROWBOTHAM MC et al.: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. (2003) 60(11):1524-1534. (Pubitemid 37443116)
9. SMITH PA: Neuropathic pain: drug targets for current and future interventions. Drug News Perspect. (2004) 17(1):5-17. (Pubitemid 38419367)
10. HANSSON P: Difficulties in stratifying neuropathic pain by mechanisms. Eur. J. Pain (2003) 7(4):353-357. (Pubitemid 36858234)
11. HARGREAVES K, DUBNER R, BROWN F, FLORES C, JORIS J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 32(1):77-88.
12. RANDALL LO, SELITTO JJ: A method for measurement of analgesic activity on inflamed tissue. Arch. Int . Pharmacodyn. Ther. (1957) 111(4):409-419.
13. CHAPLAN SR, BACH FW, POGREL JW, CHUNG JM, YAKSH TL: Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods (1994) 53(1):55-63. (Pubitemid 24238751)
14. DUBUISSON D, DENNIS SG: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain (1977) 4(2):161-174. (Pubitemid 8234766)
15. WOOLF CJ, MANNION RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet (1999) 353(9168):1959-1964.
16. ZIMMERMANN M: Pathobiology of neuropathic pain. Eur. J. Pharmacol. (2001) 429(1-3):23-37. (Pubitemid 33043979)
17. BRIDGES D, THOMPSON SW, RICE AS: Mechanisms of neuropathic pain. Br. J. Anaesth. (2001) 87(1):12-26. (Pubitemid 32631672)
18. UEDA H: Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol. Ther. (2006) 109(1-2):57-77. (Pubitemid 41740815)
19. FIELD MJ, BRAMWELL S, HUGHES J, SINGH L: Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? Pain (1999) 83(2):303-311. (Pubitemid 29479290)
20. FIELD MJ, MCCLEARY S, HUGHES J, SINGH L: Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain (1999) 80(1-2):391-398. (Pubitemid 29151725)
21. JETT MF, MCGUIRK J, WALIGORA D, HUNTER JC: The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain (1997) 69(1-2):161-169. (Pubitemid 27081422)
22. DOWDALL T, ROBINSON I, MEERT TF: Comparison of five different rat models of peripheral nerve injury. Pharmacol. Biochem. Behav. (2005) 80(1):93-108. (Pubitemid 40126207)
23. CHACUR M, MILLIGAN ED, GAZDA LS et al.: A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain (2001) 94(3):231-244. (Pubitemid 33145393)
24. FOX A, EASTWOOD C, GENTRY C, MANNING D, URBAN L: Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain (1999) 81(3):307-316. (Pubitemid 29257901)
25. LYNCH JJ 3rd, WADE CL, ZHONG CM, MIKUSA JP, HONORE P: Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain (2004) 110(1-2):56-63. (Pubitemid 38953268)
26. NIEMEGEERS CJ, VERBRUGGEN FJ, JANSSEN PA: Effect of various drugs on carrageenin-induced oedema in the rat hind paw. J. Pharm. Pharmacol. (1964) 16:810-816.
27. FERREIRA SH, LORENZETTI BB, CORRÊA FM: Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol. (1978) 53(1):39-48.
28. MONCADA S, FERREIRA SH, VANE JR: Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature (1973) 246(5430):217-219.
29. MONCADA S, FERREIRA SH, VANE JR: Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur. J. Pharmacol. (1975) 31(2):250-260.
30. HEPPELMANN B, PFEFFER A, SCHAIBLE HG, SCHMIDT RF: Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain (1986) 26(3):337-351. (Pubitemid 16016714)
31. SCHAIBLE HG, SCHMIDT RF, WILLIS WD: Enhancement of the responses of ascending tract cells in the cat spinal cord by acute inflammation of the knee joint. Exp. Brain Res. (1987) 66(3):489-499. (Pubitemid 17090784)
32. REN K, HYLDEN JL, WILLIAMS GM, RUDA MA, DUBNER R: The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain (1992) 50(3):331-344.
33. MA QP, WOOLF CJ: Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain (1996) 67(1):97-106. (Pubitemid 26319641)
34. HONORE P, MENNING PM, ROGERS SD et al.: Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J. Neurosci. (1999) 19(17):7670-7678. (Pubitemid 29404623)
35. MALMBERG AB, GILBERT H, MCCABE RT, BASBAUM AI: Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain (2003) 101(1-2):109-116. (Pubitemid 36044658)
36. VENERONI O, MAJ R, CALABRESI M et al.: Anti-allodynic effect of NW-1029, a novel Na+ channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain (2003) 102(1-2):17-25. (Pubitemid 36298858)
37. KIDD BL, URBAN LA: Mechanisms of inflammatory pain. Br. J. Anaesth. (2001) 87(1):3-11. (Pubitemid 32631671)
38. KUBOTA T, KOMATSU H, KAWAMOTO H, YAMADA T: Studies on the effects of anti-inflammatory action of benzoyl-hydrotropic acid ketoprofen and other drugs, with special reference to prostaglandin synthesis. Arch. Inter. Pharmaco. Thr. (1979) 237(1):169-176. (Pubitemid 9147489)
39. BLACKHAM A, HALL DE, MANN J, WOODS AM: Effect of cyclo-oxygenase inhibitors in models of acute and chronic inflammation. Agents Actions Suppl. (1979) 4:193-201.
40. JULOU L, GUYONNET JC, DUCROT R, FOURNEL J, PASQUET J: Ketoprofen 19583 RP 2-3-benzoylphenyl-propionic acid Main pharmacological properties-outline of toxicological and pharmacokinetic data. Scand. J. Rheumatol. (1976) 1976(0):33-44.
41. PENNING TD, TALLEY JJ, BERTENSHAW SR et al.: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-5-4- methylphenyl-3-trifluoromethyl-1H-pyrazo l-1-ylbenze nesulfonamide SC-58635, celecoxib. J. Med. Chem. (1997) 40(9):1347-1365. (Pubitemid 27198082)
42. CHAN CC, BOYCE S, BRIDEAU C et al.: Rofecoxib Vioxx, MK-0966; 4-4-methylsulfonylphenyl-3-phenyl-2- 5H-furanone: a potent and orally active cyclooxygenase-2 inhibitor pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. (1999) 290(2):551-560. (Pubitemid 29344546)
43. FERNIHOUGH J, GENTRY C, MALCANGIO M et al.: Pain related behaviour in two models of osteoarthritis in the rat knee. Pain (2004) 112(1-2):83-93. (Pubitemid 39371023)
44. COMBE R, BRAMWELL S, FIELD MJ: The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci. Lett. (2004) 370(2-3):236-240. (Pubitemid 39370885)
45. FOLEY KM: Advances in cancer pain. Arch. Neurol. (1999) 56(4):413-417. (Pubitemid 29166333)
46. SCHWEI MJ, HONORE P, ROGERS SD et al.: Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J. Neurosci. (1999) 19(24):10886-10897. (Pubitemid 30235733)
47. HONORE P, LUGER NM, SABINO MA et al.: Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. (2000) 6(5):521-528. (Pubitemid 30305901)
48. MEDHURST SJ, WALKER K, BOWES M et al.: A rat model of bone cancer pain. Pain (2002) 96(1-2):129-140. (Pubitemid 34270635)
49. LUGER NM, MACH DB, SEVCIK MA, MANTYH PW: Bone cancer pain: from model to mechanism to therapy. J. Pain Symptom Manage. (2005) 29(5 Suppl):S32-S46. (Pubitemid 40720245)
50. HONORE P, ROGERS SD, SCHWEI MJ et al.: Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience (2000) 98(3):585-598. (Pubitemid 30408178)
51. LUGER NM, SABINO MA, SCHWEI MJ et al.: Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain (2002) 99(3):397-406. (Pubitemid 35284270)
52. SABINO MA, LUGER NM, MACH DB et al.: Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. Int. J. Cancer (2003) 104(5):550-558. (Pubitemid 36337254)
53. MENENDEZ L, LASTRA A, FRESNO MF et al.: Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Res. (2003) 969(1-2):102-109. (Pubitemid 36369617)
54. WACNIK PW, KEHL LJ, TREMPE TM et al.: Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain (2003) 101(1-2):175-186. (Pubitemid 36044665)
55. VIT JP, OHARA PT, TIEN DA et al.: The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception. Pain (2006) 120(1-2):188-201. (Pubitemid 43077182)
56. BAAMONDE A, LASTRA A, FRESNO MF et al.: Implantation of tumoral XC cells induces chronic, endothelin-dependent, thermal hyperalgesia in mice. Cell Mol. Neurobiol. (2004) 24(2):269-281. (Pubitemid 38481022)
57. LINDSAY TH, JONAS BM, SEVCIK MA et al.: Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression. Pain (2005) 119(1-3):233-246. (Pubitemid 41752984)
58. LINDSAY TH, HALVORSON KG, PETERS CM et al.: A quantitative analysis of the sensory and sympathetic innervation of the mouse pancreas. Neuroscience (2006) 137(4):1417-1426. (Pubitemid 43133165)
59. NESS TJ, GEBHART GF: Visceral pain: a review of experimental studies. Pain (1990) 41(2):167-234. (Pubitemid 20179930)
60. MCMAHON SB, DMITRIEVA N, KOLTZENBURG M: Visceral pain. Br. J. Anaesth. (1995) 75(2):132-144.
61. GIAMBERARDINO MA, DE BIGONTINA P, MARTEGIANI C, VECCHIET L: Effects of extracorporeal shock-wave lithotripsy on referred hyperalgesia from renal/ureteral calculosis. Pain (1994) 56(1):77-83. (Pubitemid 24037262)
62. NESS TJ, GEBHART GF: Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. (1988) 450(1-2):153-169.
63. ECKHARDT ET, CHEPLOVITZ F, LIPO M, GOVIER WM: Etiology of chemically induced writhing in mouse and rat. Proc. Soc. Exp. Biol. Med. (1958) 98(1):186-188.
64. LE BARS D, GOZARIU M, CADDEN SW: Animal models of nociception. Pharmacol. Rev. (2001) 53(4):597-652. (Pubitemid 33136239)
65. COUTINHO SV, MELLER ST, GEBHART GF: Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res. (1996) 736(1-2):7-15. (Pubitemid 26356457)
66. SENGUPTA JN, SNIDER A, SU X, GEBHART GF: Effects of opioids in the inflamed rat colon. Pain (1999) 79(2-3):175-185. (Pubitemid 29076752)
67. BURTON MB, GEBHART GF: Effects of -opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J. Pharmacol. Exp. Ther. (1998) 285(2):707-715. (Pubitemid 28237452)
68. JOSHI SK, GEBHART GF: Visceral pain. Curr. Rev. Pain (2000) 4(6):499-506.
69. OMOTE K, KAWAMATA M, IWASAKI H, NAMIKI A: Effects of morphine on neuronal and behavioural responses to visceral and somatic nociception at the level of spinal cord. Acta Anaesthesiol. Scand. (1994) 38(5):514-517. (Pubitemid 24204474)
70. HARADA Y, NISHIOKA K, KITAHATA LM, NAKATANI K, COLLINS JG: Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat. Anesthesiology (1995) 83(2):336-343.
71. NIJSEN MJ, ONGENAE NG, COULIE B, MEULEMANS AL: Telemetric animal model to evaluate visceral pain in the freely moving rat. Pain (2003) 105(1-2):115-123. (Pubitemid 37162480)
72. TAMMPERE A, BRUSBERG M, AXENBORG J et al.: Evaluation of pseudo-affective responses to noxious colorectal distension in rats by manometric recordings. Pain (2005) 116(3):220-226. (Pubitemid 40957125)
73. ROUZADE ML, FIORAMONTI J, BUENO L: A model for evaluation of gastric sensitivity in awake rats. Neurogastroenterol. Motil. (1998) 10(2):157-163. (Pubitemid 28181881)
74. FENG Y, CUI M, AL-CHAER ED, WILLIS WD: Epigastric antinociception by cervical dorsal column lesions in rats. Anesthesiology (1998) 89(2):411-420. (Pubitemid 28373431)
75. NESS TJ, LEWIS-SIDES A, CASTROMAN P: Characterization of pressor and visceromotor reflex responses to bladder distention in rats: sources of variability and effect of analgesics. J. Urol. (2001) 165(3):968-974. (Pubitemid 32156333)
76. NESS TJ, ELHEFNI H: Reliable visceromotor responses are evoked by noxious bladder distention in mice. J. Urol. (2004) 171(4):1704-1708. (Pubitemid 38365468)
77. BOUCHER M, MEEN M, CODRON JP et al.: Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J. Urol. (2000) 164(1):203-208. (Pubitemid 30434301)
78. AL-CHAER ED, KAWASAKI M, PASRICHA PJ: A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology (2000) 119(5):1276-1285.
79. COUTINHO SV, PLOTSKY PM, SABLAD M et al.: Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am. J. Physiol. Gastrointest. Liver Physiol. (2002) 282(2):G307-G316. (Pubitemid 34651687)
80. HILL R: NK1 (substance P) receptor antagonists - why are they not analgesic in humans? Trends Pharmacol. Sci. (2000) 21(7):244-246. (Pubitemid 30445249)
81. COSTELLO JC, HALVERSON PB: A new era in rheumatoid arthritis treatment. WMJ (2003) 102(7):29-33. (Pubitemid 37523555)
82. BOSTOCK H, CAMPERO M, SERRA J, OCHOA JL: Temperature-dependent double spikes in C-nociceptors of neuropathic pain patients. Brain (2005) 128(Part 9):2154-2163. (Pubitemid 41253282)
83. KLEIN T, MAGERL W, ROLKE R, TREEDE RD: Human surrogate models of neuropathic pain. Pain (2005) 115(3):227-233. (Pubitemid 40725278)
84. STAAHL C, DREWES AM: Experimental human pain models: a review of standardised methods for preclinical testing of analgesics. Basic Clin. Pharmacol. Toxicol. (2004) 95(3):97-111. (Pubitemid 39331302)